-
SunSirs: Due to Weak Costs, the Market Price of Polyamide Filament Continued to Decline Weakly
2025-10-27 10:15:23 SunSirsPrice trend Last week (October 20-24, 2025), the center of polyamide PA6 chips upstream of polyamide filament moved downward, the support on the cost side weakened, the supply in
-
SunSirs: Polyamide Filament Prices Fell in the Third Quarter and May Continue to Fall in the Fourth Quarter
2025-10-24 09:31:42 SunSirsPrice trend In the third quarter of 2025, the polyamide filament market lacked favorable conditions, with prices generally trending downward. Taking polyamide DTY as an
-
SunSirs: Oversupply, Polyamide Filament Market Continued to Decline
2025-10-23 10:10:14 SunSirsLast week (October 13-19, 2025), the market trend of polyamide PA6 chips upstream of polyamide filament was weak, favorable support on the cost side was hard to find,
-
SunSirs: The Golden September Was Not Present, and the Price of Polyamide Filament Was Running Weakly at a Low Level in September
2025-10-09 10:02:32 SunSirsIn September 2025, the raw materials for polyamide filament insufficiently supported, the supply and demand performance was bearish, the shipments from polyamide factories continued to
-
SunSirs: Outlook for Polyamide Filament Market Last Week
2025-09-28 14:19:36Introduction Based on the latest analysis from SunSirs (dated September 26, 2025), the polyamide filament market continues to face downward pressure amid weak upstream support and
-
SunSirs: Raw Materials Were Generally Stable with Slight Fluctuations, and the Polyamide Filament Market Was Operating in a Consolidation
2025-09-25 14:18:03 SunSirsPrice trend Last week (September 15-21, 2025), demand remained weak, and there was no significant improvement in terminal market demand. Downstream factories mostly maintained just-in-time
-
SunSirs: Demand Remained Weak, and the Polyamide Filament Market Remained Weak and Stable
2025-09-17 09:09:31 SunSirsPrice trend Last week (September 8-14, 2025), demand remained weak, and the polyamide filament market remained weak and stable. Sinopec's high-end caprolactam settled at 9,184

